Vandetanib is a once-daily oral inhibitor of vascular endothelial growth factor receptor-2 and epidermal growth factor receptor kinase activity. The activity of Vandetanib plus Docetaxel was assessed in patients with previously treated non-small-cell lung cancer (NSCLC).
SKU | RCLST001790 |
---|---|
CAS number | 443913-73-3 |
Molecular Formula | C22H24BrFN4O2 |
Catalog Number | RCLST001790 |
Chemical Name | Vandetanib |
Synonyms | N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine; 4-(4-Bromo-2-fluoroanilino)-6-methoxy- 7-[(1-methylpiperidin-4-yl)methoxy]quinazoline; ZD 6474; Zactima; |
Molecular Weight | 475.35 |
Solubility | DMSO (Slightly, Heated), Methanol (Slightly, Heated) |
Stability | No Data Available |
Appearance | White to Pale Yellow Solid |
Storage Condition | -20˚C Freezer |